PubRank

Kent W Hunter

Author PubWeight™ 50.27‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Genetic dissection of complex and quantitative traits: from fantasy to reality via a community effort. Mamm Genome 2002 3.02
2 Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1. Nat Genet 2005 2.92
3 Syngeneic mouse mammary carcinoma cell lines: two closely related cell lines with divergent metastatic behavior. Clin Exp Metastasis 2005 2.52
4 Bromodomain 4 activation predicts breast cancer survival. Proc Natl Acad Sci U S A 2008 2.15
5 Germline polymorphisms in SIPA1 are associated with metastasis and other indicators of poor prognosis in breast cancer. Breast Cancer Res 2006 1.81
6 Integrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survival. Gastroenterology 2011 1.68
7 Global expression profiling identifies signatures of tumor virulence in MMTV-PyMT-transgenic mice: correlation to human disease. Cancer Res 2004 1.57
8 Rrp1b, a new candidate susceptibility gene for breast cancer progression and metastasis. PLoS Genet 2007 1.55
9 A high-resolution multistrain haplotype analysis of laboratory mouse genome reveals three distinctive genetic variation patterns. Genome Res 2005 1.50
10 Metastasis predictive signature profiles pre-exist in normal tissues. Clin Exp Metastasis 2006 1.43
11 Multiple cross and inbred strain haplotype mapping of complex-trait candidate genes. Genome Res 2003 1.41
12 The Diasporin Pathway: a tumor progression-related transcriptional network that predicts breast cancer survival. Clin Exp Metastasis 2008 1.36
13 Modeling metastasis biology and therapy in real time in the mouse lung. J Clin Invest 2010 1.32
14 Cadm1 is a metastasis susceptibility gene that suppresses metastasis by modifying tumor interaction with the cell-mediated immunity. PLoS Genet 2012 1.27
15 Accelerated preclinical testing using transplanted tumors from genetically engineered mouse breast cancer models. Clin Cancer Res 2007 1.22
16 Distinct inherited metastasis susceptibility exists for different breast cancer subtypes: a prognosis study. Breast Cancer Res 2009 1.19
17 Deletion of the proline-rich region of the murine metastasis susceptibility gene Brd4 promotes epithelial-to-mesenchymal transition- and stem cell-like conversion. Cancer Res 2011 1.16
18 Modifiers of mammary tumor progression and metastasis on mouse chromosomes 7, 9, and 17. Mamm Genome 2005 1.10
19 Integrated cross-species transcriptional network analysis of metastatic susceptibility. Proc Natl Acad Sci U S A 2012 1.03
20 The origins of breast cancer prognostic gene expression profiles. Cancer Res 2009 1.02
21 A bioinformatics-based strategy identifies c-Myc and Cdc25A as candidates for the Apmt mammary tumor latency modifiers. Genome Res 2002 1.01
22 The metastasis efficiency modifier ribosomal RNA processing 1 homolog B (RRP1B) is a chromatin-associated factor. J Biol Chem 2009 0.97
23 Comparative sequence analysis in eight inbred strains of the metastasis modifier QTL candidate gene Brms1. Mamm Genome 2002 0.94
24 Allelic variation and differential expression of the mSIN3A histone deacetylase complex gene Arid4b promote mammary tumor growth and metastasis. PLoS Genet 2012 0.92
25 Mouse modifier genes in mammary tumorigenesis and metastasis. J Mammary Gland Biol Neoplasia 2008 0.90
26 An integrated systems genetics screen reveals the transcriptional structure of inherited predisposition to metastatic disease. Genome Res 2013 0.89
27 Inherited variation in miR-290 expression suppresses breast cancer progression by targeting the metastasis susceptibility gene Arid4b. Cancer Res 2013 0.89
28 Genotype X diet interactions in mice predisposed to mammary cancer. I. Body weight and fat. Mamm Genome 2008 0.89
29 BRD4 short isoform interacts with RRP1B, SIPA1 and components of the LINC complex at the inner face of the nuclear membrane. PLoS One 2013 0.88
30 Dietary fat alters pulmonary metastasis of mammary cancers through cancer autonomous and non-autonomous changes in gene expression. Clin Exp Metastasis 2010 0.88
31 DNA methyltransferase inhibitor, zebularine, delays tumor growth and induces apoptosis in a genetically engineered mouse model of breast cancer. Mol Cancer Ther 2011 0.87
32 Genotype X diet interactions in mice predisposed to mammary cancer: II. Tumors and metastasis. Mamm Genome 2008 0.87
33 Genetic background may contribute to PAM50 gene expression breast cancer subtype assignments. PLoS One 2013 0.86
34 Bromodomain-Containing Protein 4: A Dynamic Regulator of Breast Cancer Metastasis through Modulation of the Extracellular Matrix. Int J Breast Cancer 2011 0.85
35 Dietary fat-dependent transcriptional architecture and copy number alterations associated with modifiers of mammary cancer metastasis. Clin Exp Metastasis 2010 0.85
36 A new member of the growing family of metastasis suppressors identified in prostate cancer. J Natl Cancer Inst 2003 0.84
37 Polymorphisms of the SIPA1 gene and sporadic breast cancer susceptibility. BMC Cancer 2009 0.83
38 Parallel analysis of transcript and translation profiles: identification of metastasis-related signal pathways differentially regulated by drug and genetic modifications. J Proteome Res 2006 0.83
39 New perspectives on hereditary influences in metastatic progression. Trends Genet 2006 0.79
40 Context-dependent cancer risk. Nat Genet 2006 0.76
41 Using a systems biology approach to understand and study the mechanisms of metastasis. Wiley Interdiscip Rev Syst Biol Med 2013 0.75
42 A systems biology approach to defining metastatic biomarkers and signaling pathways. Wiley Interdiscip Rev Syst Biol Med 2010 0.75